OPKO Health, Inc. Net Income (Loss) Available to Common Stockholders, Basic
OPKO Health, Inc. (OPK) reported Net Income (Loss) Available to Common Stockholders, Basic of $21.63 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-10-29.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2025-10-29
- OPKO Health, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was $21.63M, a 13.09% decline year-over-year.
- OPKO Health, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-09-30 was $24.89M.
- OPKO Health, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2023-09-30 was -$84.47M.
- OPKO Health, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2018-06-30 was -$6.20M.
- OPKO Health, Inc. net income (loss) available to common stockholders, basic for fiscal 2014 was -$171.67M.
- OPKO Health, Inc. net income (loss) available to common stockholders, basic for fiscal 2013 was -$114.83M.
- OPKO Health, Inc. net income (loss) available to common stockholders, basic for fiscal 2012 was -$31.29M.
- OPKO Health, Inc. net income (loss) available to common stockholders, basic for fiscal 2011 was -$3.66M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-09-30 | $21.63M 10-Q · filed 2025-10-29 | ||||||
| 2024-09-30 | $24.89M 10-Q · filed 2025-10-29 | -$67.25M 10-Q · filed 2024-11-07 | |||||
| 2023-09-30 | -$84.47M 10-Q · filed 2024-11-07 | -$122.38M 10-Q · filed 2024-11-07 | |||||
| 2018-06-30 | -$6.20M 10-Q · filed 2018-08-07 | -$49.31M 10-Q · filed 2018-08-07 | |||||
| 2017-12-31 | -$217.91M 8-K · filed 2019-01-29 | -$213.91M 10-K · filed 2018-03-01 | -$253.83M derived: sum of 2 quarters · filed 2019-01-29 | -$270.75M derived: sum of 3 quarters · filed 2019-01-29 | -$305.25M 8-K · filed 2019-01-29 | -$308.87M 10-K · filed 2018-03-01 | |
| 2017-09-30 | -$35.92M 8-K · filed 2019-01-29 | -$46.44M 10-K · filed 2018-03-01 | -$52.83M derived: sum of 2 quarters · filed 2019-01-29 | -$87.34M derived: sum of 3 quarters · filed 2019-01-29 | -$109.12M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2017-06-30 | -$16.92M 8-K · filed 2019-01-29 | -$17.53M 10-Q · filed 2017-08-08 | -$51.42M 10-Q · filed 2018-08-07 | -$48.52M 10-Q · filed 2017-08-08 | -$73.20M derived: sum of 3 quarters · filed 2019-01-29 | -$95.44M derived: sum of 4 quarters · filed 2019-01-29 | |
| 2017-03-31 | -$34.50M 8-K · filed 2019-01-29 | -$31.00M 10-K · filed 2018-03-01 | -$56.29M derived: sum of 2 quarters · filed 2019-01-29 | -$78.53M derived: sum of 3 quarters · filed 2019-01-29 | -$67.62M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2016-12-31 | -$21.79M 8-K · filed 2019-01-29 | -$13.66M 10-K · filed 2017-03-01 | -$44.02M derived: sum of 2 quarters · filed 2019-01-29 | -$33.11M derived: sum of 3 quarters · filed 2019-01-29 | -$48.36M 8-K · filed 2019-01-29 | -$25.08M 10-K · filed 2017-03-01 | |
| 2016-09-30 | -$22.24M 8-K · filed 2019-01-29 | -$14.98M 10-Q · filed 2016-11-07 | -$11.33M derived: sum of 2 quarters · filed 2019-01-29 | -$11.42M 10-Q · filed 2016-11-07 | -$24.97M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2016-06-30 | $10.91M 8-K · filed 2019-01-29 | $15.53M 10-Q · filed 2016-08-08 | $3.55M 10-Q · filed 2017-08-08 | -$2.73M derived: sum of 3 quarters · filed 2019-01-29 | $125.52M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2016-03-31 | -$15.24M 8-K · filed 2019-01-29 | -$11.98M 10-Q · filed 2016-05-09 | -$13.64M derived: sum of 2 quarters · filed 2019-01-29 | $114.61M derived: sum of 3 quarters · filed 2019-01-29 | $71.84M derived: sum of 4 quarters · filed 2019-01-29 | ||
| 2015-12-31 | $1.60M 10-K · filed 2017-03-01 | $129.85M derived: sum of 2 quarters · filed 2017-03-01 | $87.08M derived: sum of 3 quarters · filed 2017-03-01 | -$52.13M 8-K · filed 2019-01-29 | -$30.03M 10-K · filed 2016-02-29 | ||
| 2015-09-30 | $128.25M 10-K · filed 2017-03-01 | $85.48M derived: sum of 2 quarters · filed 2017-03-01 | -$31.63M 10-Q · filed 2016-11-07 | -$84.60M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | -$42.77M 10-K · filed 2017-03-01 | -$159.88M 10-Q · filed 2016-08-08 | -$212.85M derived: sum of 3 quarters · filed 2017-03-01 | -$261.52M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | -$117.11M 10-K · filed 2017-03-01 | -$170.08M derived: sum of 2 quarters · filed 2017-03-01 | -$218.75M derived: sum of 3 quarters · filed 2017-03-01 | -$244.23M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | -$52.97M 10-K · filed 2016-02-29 | -$101.64M derived: sum of 2 quarters · filed 2016-02-29 | -$127.12M derived: sum of 3 quarters · filed 2016-02-29 | -$171.67M 10-K · filed 2017-03-01 | |||
| 2014-09-30 | -$48.67M 10-K · filed 2016-02-29 | -$74.15M derived: sum of 2 quarters · filed 2016-02-29 | -$118.69M 10-Q · filed 2015-11-09 | -$135.50M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | -$25.48M 10-K · filed 2016-02-29 | -$25.48M 10-Q · filed 2014-08-11 | -$70.03M 10-Q · filed 2015-08-05 | -$86.83M derived: sum of 3 quarters · filed 2016-02-29 | -$146.82M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | -$44.55M 10-K · filed 2016-02-29 | -$44.55M 10-Q · filed 2014-05-09 | -$61.35M derived: sum of 2 quarters · filed 2016-02-29 | -$121.35M derived: sum of 3 quarters · filed 2016-02-29 | -$124.74M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | -$16.80M 10-K · filed 2015-02-27 | -$76.80M derived: sum of 2 quarters · filed 2015-02-27 | -$80.19M derived: sum of 3 quarters · filed 2015-02-27 | -$114.83M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | -$60.00M 10-K · filed 2015-02-27 | -$63.39M derived: sum of 2 quarters · filed 2015-02-27 | -$98.03M 10-Q · filed 2014-11-07 | -$99.13M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-06-30 | -$3.39M 10-K · filed 2015-02-27 | -$38.03M 10-Q · filed 2014-08-11 | -$39.13M derived: sum of 3 quarters · filed 2015-02-27 | -$49.34M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-03-31 | -$34.63M 10-K · filed 2015-02-27 | -$35.74M derived: sum of 2 quarters · filed 2015-02-27 | -$45.95M derived: sum of 3 quarters · filed 2015-02-27 | -$56.75M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | -$1.11M 10-K · filed 2014-03-03 | -$11.31M derived: sum of 2 quarters · filed 2014-03-03 | -$22.12M derived: sum of 3 quarters · filed 2014-03-03 | -$31.29M 10-K · filed 2015-02-27 | |||
| 2012-09-30 | -$10.21M 10-K · filed 2014-03-03 | -$21.01M derived: sum of 2 quarters · filed 2014-03-03 | -$30.18M 10-Q · filed 2013-11-12 | -$12.30M derived: sum of 4 quarters · filed 2014-03-03 | |||
| 2012-06-30 | -$10.80M 10-K · filed 2014-03-03 | -$19.97M 10-Q · filed 2013-08-09 | -$2.09M derived: sum of 3 quarters · filed 2014-03-03 | -$10.93M derived: sum of 4 quarters · filed 2014-03-03 | |||
| 2012-03-31 | -$9.17M 10-K · filed 2014-03-03 | $8.71M derived: sum of 2 quarters · filed 2014-03-03 | -$123.00K derived: sum of 3 quarters · filed 2014-03-03 | -$6.48M derived: sum of 4 quarters · filed 2014-03-03 | |||
| 2011-12-31 | $17.88M 10-K · filed 2013-03-18 | $9.05M derived: sum of 2 quarters · filed 2013-03-18 | $2.69M derived: sum of 3 quarters · filed 2013-03-18 | -$3.66M 10-K · filed 2014-03-03 | |||
| 2011-09-30 | -$8.84M 10-K · filed 2013-03-18 | -$15.20M derived: sum of 2 quarters · filed 2013-03-18 | -$21.55M 10-Q · filed 2012-11-09 | -$22.86M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-06-30 | -$6.36M 10-K · filed 2013-03-18 | -$12.71M 10-Q · filed 2012-08-09 | -$14.03M derived: sum of 3 quarters · filed 2013-03-18 | -$22.04M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-03-31 | -$6.35M 10-K · filed 2013-03-18 | -$7.67M derived: sum of 2 quarters · filed 2013-03-18 | -$15.68M derived: sum of 3 quarters · filed 2013-03-18 | -$22.55M derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2010-12-31 | -$1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$9.33M derived: sum of 2 quarters · filed 2013-03-18 | -$16.20M derived: sum of 3 quarters · filed 2013-03-18 | -$21.55M 10-K · filed 2013-03-18 | |||
| 2010-09-30 | -$8.01M 10-Q · filed 2011-11-09 | -$14.89M derived: sum of 2 quarters · filed 2011-11-09 | -$20.23M 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | -$6.88M 10-Q · filed 2011-08-08 | -$12.22M 10-Q · filed 2011-08-08 | |||||
| 2009-12-31 | -$34.83M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |